Novel tissue factor targeted antibodies as anticoagulants
Details for Australian Patent Application No. 2003225255 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/376,566 01.05.02 US
8 January 2004 Application Open to Public Inspection
Published as AU-B-2003225255
31 July 2008 Application Accepted
Published as AU-B-2003225255
7 August 2008 Alteration of Name
The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft
27 November 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003225256-Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser